213 related articles for article (PubMed ID: 18694510)
1. Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells.
Selga E; Morales C; Noé V; Peinado MA; Ciudad CJ
BMC Med Genomics; 2008 Aug; 1():35. PubMed ID: 18694510
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
[TBL] [Abstract][Full Text] [Related]
3. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.
Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA
Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate: role in the cell cycle and apoptosis.
Selga E; Noé V; Ciudad CJ
Biochem Pharmacol; 2008 Jan; 75(2):414-26. PubMed ID: 17945194
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of folate binding protein alpha is one of the mechanism explaining the adaptation of HT29 cells to high concentration of methotrexate.
de Nonancourt-Didion M; Guéant JL; Adjalla C; Chéry C; Hatier R; Namour F
Cancer Lett; 2001 Oct; 171(2):139-45. PubMed ID: 11520597
[TBL] [Abstract][Full Text] [Related]
6. Networking of differentially expressed genes in human cancer cells resistant to methotrexate.
Selga E; Oleaga C; Ramírez S; de Almagro MC; Noé V; Ciudad CJ
Genome Med; 2009 Sep; 1(9):83. PubMed ID: 19732436
[TBL] [Abstract][Full Text] [Related]
7. Underexpression of miR-224 in methotrexate resistant human colon cancer cells.
Mencia N; Selga E; Noé V; Ciudad CJ
Biochem Pharmacol; 2011 Dec; 82(11):1572-82. PubMed ID: 21864507
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH.
Peñuelas S; Noé V; Morales R; Ciudad CJ
Med Sci Monit; 2005 Jan; 11(1):BR6-12. PubMed ID: 15614187
[TBL] [Abstract][Full Text] [Related]
9. Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.
Peñuelas S; Noé V; Ciudad CJ
FEBS J; 2005 Feb; 272(3):696-710. PubMed ID: 15670151
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
Hattinger CM; Stoico G; Michelacci F; Pasello M; Scionti I; Remondini D; Castellani GC; Fanelli M; Scotlandi K; Picci P; Serra M
Genes Chromosomes Cancer; 2009 Apr; 48(4):289-309. PubMed ID: 19105235
[TBL] [Abstract][Full Text] [Related]
11. Identification of AGT and CD44 in methotrexate-resistant colorectal cancer and reversal of methotrexate-resistance.
Su Q; Song J; Zhang X; Jiang Y; Gao H
Pathol Res Pract; 2022 Jan; 229():153717. PubMed ID: 34952427
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
13. Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells.
Meng X; Qi X; Guo H; Cai M; Li C; Zhu J; Chen F; Guo H; Li J; Zhao Y; Liu P; Jia X; Yu J; Zhang C; Sun W; Yu Y; Jin Y; Bai J; Wang M; Rosales J; Lee KY; Fu S
J Med Genet; 2015 Feb; 52(2):135-44. PubMed ID: 25537274
[TBL] [Abstract][Full Text] [Related]
14. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.
Hattinger CM; Reverter-Branchat G; Remondini D; Castellani GC; Benini S; Pasello M; Manara MC; Scotlandi K; Picci P; Serra M
Eur J Cell Biol; 2003 Sep; 82(9):483-93. PubMed ID: 14582536
[TBL] [Abstract][Full Text] [Related]
15. Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations.
Kitamura H; Cho M; Lee BH; Gum JR; Siddiki BB; Ho SB; Toribara NW; Lesuffleur T; Zweibaum A; Kitamura Y; Yonezawa S; Kim YS
Eur J Cancer; 1996 Sep; 32A(10):1788-96. PubMed ID: 8983291
[TBL] [Abstract][Full Text] [Related]
16. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
17. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
19. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
Xian D; Zhao Y
J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
[TBL] [Abstract][Full Text] [Related]
20. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
